TGF-β was discovered to suppress the growth of many cells, including epithelial cells, blood cells, lymphocytes, and vascular endothelial cells, in the mid-1980s, and its tumor-suppressing effects have attracted attention in relation to cancer for a long time. This evidence concerns the gene TGFB1 and neoplasm.